Tema ETFs · 2023-08-14 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-08-02 | -$3.6M | — | — | $190.0M | 每日估算 |
| 2026-08-01 | +$6.6M | — | — | $197.0M | 每日估算 |
| 2026-07-31 | -$6.1M | — | — | $193.7M | 每日估算 |
| 2026-07-30 | +$3.1M | — | — | $196.4M | 每日估算 |
| 2026-07-29 | -$227,556 | — | — | $196.1M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
RVMD Revolution Medicines Inc | EC | 98,581 | $10.1M | 6.29% |
NOVN Novartis AG | EC | 46,684 | $7.9M | 4.96% |
BBIO Bridgebio Pharma Inc | EC | 114,318 | $7.6M | 4.75% |
AZN AstraZeneca PLC | EC | 35,320 |
行情与风险截至 2026-07-31；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-28 | +$5.7M | — | — | $195.9M | 每日估算 |
| 2026-07-27 | -$5.9M | — | — | $190.0M | 每日估算 |
| 2026-07-26 | +$1.1M | — | — | $197.0M | 每日估算 |
| 2026-07-25 | +$1.1M | — | — | $197.0M | 每日估算 |
| 2026-02-28 | +$9.0M | $9.0M | $0 | $159.9M | SEC 月度 |
| 2026-01-31 | +$23.5M | $23.5M | $0 | — | SEC 月度 |
| 2025-12-31 | +$13.6M | $13.6M | $0 | — | SEC 月度 |
| $7.4M |
| 4.63% |
LLY Eli Lilly & Co | EC | 6,565 | $6.9M | 4.32% |
BMY Bristol-Myers Squibb Co | EC | 108,187 | $6.7M | 4.22% |
RHHBY Roche Holding AG | EC | 108,952 | $6.5M | 4.06% |
MRK Merck & Co Inc | EC | 49,630 | $6.1M | 3.84% |
ACLX Arcellx Inc | EC | 48,346 | $5.5M | 3.44% |
COGT Cogent Biosciences Inc | EC | 135,358 | $5.3M | 3.29% |
NUVL Nuvalent Inc | EC | 49,239 | $5.0M | 3.14% |
GMAB Genmab A/S | EC | 169,724 | $5.0M | 3.13% |
IMNM Immunome Inc | EC | 195,451 | $4.3M | 2.67% |
JNJ Johnson & Johnson | EC | 16,257 | $4.0M | 2.53% |
CELC Celcuity Inc | EC | 35,371 | $4.0M | 2.47% |
AMGN Amgen Inc | EC | 10,122 | $3.9M | 2.46% |
ABBV AbbVie Inc | EC | 16,712 | $3.9M | 2.43% |
EXEL Exelixis Inc | EC | 79,639 | $3.5M | 2.19% |
IDYA Ideaya Biosciences Inc | EC | 89,238 | $2.9M | 1.80% |
ONC BeOne Medicines Ltd | EC | 8,960 | $2.8M | 1.78% |
SNDX Syndax Pharmaceuticals Inc | EC | 127,353 | $2.8M | 1.73% |
CGON CG oncology Inc | EC | 45,885 | $2.7M | 1.69% |
ZLAB Zai Lab Ltd | EC | 121,279 | $2.3M | 1.46% |
ERAS Erasca Inc | EC | 169,487 | $2.3M | 1.45% |
ZYME Zymeworks Inc | EC | 96,723 | $2.3M | 1.41% |
LEGN Legend Biotech Corp | EC | 115,409 | $2.2M | 1.37% |
NUVB Nuvation Bio Inc | EC | 362,046 | $2.1M | 1.34% |
HALO Halozyme Therapeutics Inc | EC | 29,868 | $2.1M | 1.30% |
4519 Chugai Pharmaceutical Co Ltd | EC | 30,652 | $2.1M | 1.28% |
SMMT Summit Therapeutics Inc | EC | 110,918 | $1.8M | 1.15% |
ANAB AnaptysBio Inc | EC | 28,657 | $1.6M | 0.99% |
NRIX Nurix Therapeutics Inc | EC | 97,555 | $1.6M | 0.97% |
REGN Regeneron Pharmaceuticals Inc | EC | 1,982 | $1.5M | 0.97% |
CRVS Corvus Pharmaceuticals Inc | EC | 82,148 | $1.5M | 0.94% |
URGN UroGen Pharma Ltd | EC | 67,164 | $1.5M | 0.91% |
RLAY Relay Therapeutics Inc | EC | 142,040 | $1.5M | 0.91% |
GILD Gilead Sciences Inc | EC | 9,272 | $1.4M | 0.86% |
OLMA Olema Pharmaceuticals Inc | EC | 56,608 | $1.4M | 0.86% |
DAWN Day One Biopharmaceuticals Inc | EC | 121,928 | $1.3M | 0.81% |
ARGX Argenx SE | EC | 1,663 | $1.3M | 0.80% |
TERN Terns Pharmaceuticals Inc | EC | 28,018 | $1.2M | 0.74% |
FXFXX First American Treasury Obligations Fund | STIV | 1,026,901 | $1.0M | 0.64% |
XNCR Xencor Inc | EC | 76,928 | $982,371 | 0.61% |
TYRA Tyra Biosciences Inc | EC | 28,438 | $947,270 | 0.59% |
GH Guardant Health Inc | EC | 10,008 | $939,751 | 0.59% |
RCUS Arcus Biosciences Inc | EC | 45,953 | $936,063 | 0.59% |
AVBP ArriVent Biopharma Inc | EC | 40,743 | $935,867 | 0.59% |
IMCR Immunocore Holdings PLC | EC | 28,275 | $913,283 | 0.57% |
HCM HUTCHMED China Ltd | EC | 62,129 | $890,309 | 0.56% |
GLUE Monte Rosa Therapeutics Inc | EC | 45,524 | $808,051 | 0.51% |
CGEM Cullinan Therapeutics Inc | EC | 47,065 | $729,508 | 0.46% |
CMPX Compass Therapeutics Inc | EC | 127,476 | $720,239 | 0.45% |
JANX Janux Therapeutics Inc | EC | 47,193 | $642,297 | 0.40% |
NTRA Natera Inc | EC | 3,049 | $634,314 | 0.40% |
ARVN Arvinas Inc | EC | 45,326 | $601,476 | 0.38% |
ORIC ORIC Pharmaceuticals Inc | EC | 35,407 | $476,224 | 0.30% |